Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Patients with T2 hepatocellular carcinoma (HCC) can obtain an exception that allows them to undergo liver transplantation with much lower actual Model for End-Stage Liver Disease (MELD) scores than patients without HCC. We compared patients who received liver transplants, with and without HCC, with regard to transplantation-related survival benefit.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Gastroenterology

Title: Gastroenterology

Publisher: Elsevier BV

ISSN (Electronic): 1528-0012

ISSN (Print): 0016-5085

Publication date (Electronic): Sep 2015

Volume: 149

Issue: 3

Affiliations

[1 ] Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, Washington.

[2 ] Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, Washington; Division of Gastroenterology, Department of Medicine, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington. Electronic address: georgei@medicine.washington.edu.

Article

Publisher Item ID: S0016-5085(15)00719-2

DOI: 10.1053/j.gastro.2015.05.025

PubMed ID: 26021233

SO-VID: 08861640-555a-4ec5-b4de-857e13b8ba8b

History

Keywords: Exception Points,Liver Cancer,Priority,UNOS

Data availability:

Keywords: Exception Points, Liver Cancer, Priority, UNOS

Comments

Comment on this article

scite_

Cited by 13

See all cited by